Loughborough, United Kingdom

Stephen St Gallay

This inventor holds 1 USPTO granted patent. Top assignee: Abbott Gmbh & Co Kg. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stephen St Gallay. Retrieved from https://idiyas.com/inventor/stephen-st-gallay-0zjcskdo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 70(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Stephen St Gallay

Introduction

Stephen St Gallay is a notable inventor based in Loughborough, GB. He has made significant contributions to the field of therapeutic agents, particularly through his work on kinase inhibitors. His innovative approach has led to the development of compounds that hold promise for various medical applications.

Latest Patents

Stephen St Gallay holds a patent for "Kinase inhibitors as therapeutic agents." This patent is directed to a compound of Formula (I), which is defined in the application and is useful as a kinase inhibitor. This invention showcases his commitment to advancing medical science and improving therapeutic options.

Career Highlights

Stephen is currently associated with Abbott GmbH & Co. KG, a leading global healthcare company. His role at Abbott allows him to leverage his expertise in developing innovative solutions that address critical health challenges. His work has been instrumental in pushing the boundaries of what is possible in the field of pharmaceuticals.

Collaborations

Stephen has collaborated with notable colleagues, including Gavin C Hirst and Paul Rafferty. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries.

Conclusion

Stephen St Gallay's contributions to the field of kinase inhibitors exemplify the impact of dedicated inventors in advancing healthcare. His work continues to inspire future innovations in therapeutic agents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…